Advanced search
Publication Cover
Journal of Medical Economics Volume 18, 2015 - Issue 12
Submit an article Journal homepage
659
Views
5
CrossRef citations to date
0
Altmetric
Original Article

The budget impact of introducing delayed-release dimethyl fumarate for treatment of relapse-remitting multiple sclerosis in Canada

Emily DormanEvidera, Bethesda, MD, USA
,
Anuraag R. KansalEvidera, Bethesda, MD, USACorrespondence[email protected]
&
Sujata SardaBiogen Idec, Cambridge, MA, USA
Pages 1085-1091 | Accepted 23 Jul 2015, Published online: 20 Aug 2015

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Wenqing Su, Anuraag Kansal, Colin Vicente, Baris Deniz & Sujata Sarda. (2016) The cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis in Canada. Journal of Medical Economics 19:7, pages 718-727.
Read now

Articles from other publishers (4)

Christina Tryfonos, Maria Mantzorou, Dimitris Fotiou, Michael Vrizas, Konstantinos Vadikolias, Eleni Pavlidou & Constantinos Giaginis. (2019) Dietary Supplements on Controlling Multiple Sclerosis Symptoms and Relapses: Current Clinical Evidence and Future Perspectives. Medicines 6:3, pages 95.
Crossref
Ricardo Constantino Ginestal López. (2018) Eficiencia de las nuevas opciones terapéuticas para el tratamiento de la esclerosis múltiple; una revisión farmacoeconómica. PharmacoEconomics Spanish Research Articles 15:1-4, pages 3-12.
Crossref
Jacqueline Nicholas, Aaron Boster, Ning Wu, Wei-Shi Yeh, Monica Fay, Jon Kendter, Ming-Yi Huang & Andrew Lee. (2017) Comparison of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of Healthcare Resource Utilization and Relapse Rates from US Insurance Claims Data. PharmacoEconomics - Open 2:1, pages 31-41.
Crossref
Andrew Chan, Gary Cutter, Robert J Fox, James Xiao, James B Lewin & Michael R Edwards. (2017) Comparative effectiveness of delayed-release dimethyl fumarate versus glatiramer acetate in multiple sclerosis patients: results of a matching-adjusted indirect comparison. Journal of Comparative Effectiveness Research 6:4, pages 313-323.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.